Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy.
Marinkovic M, Pors LJ, van den Berg V, Peters FP, Schalenbourg A, Zografos L, Pica A, Hrbacek J, Van Duinen SG, Vu THK, Bleeker JC, Rasch CRN, Jager MJ, Luyten GPM, Horeweg N. Marinkovic M, et al. Among authors: vu thk. Cancers (Basel). 2021 Dec 13;13(24):6241. doi: 10.3390/cancers13246241. Cancers (Basel). 2021. PMID: 34944862 Free PMC article.
The Immunology of Glaucoma.
Vu TH, Jager MJ, Chen DF. Vu TH, et al. Asia Pac J Ophthalmol (Phila). 2012 Sep-Oct;1(5):303-11. doi: 10.1097/APO.0b013e31826f57a3. Asia Pac J Ophthalmol (Phila). 2012. PMID: 26107602 Free article.
Comparison of Magnetic Resonance Imaging-Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma.
Jaarsma-Coes MG, Ferreira TA, Marinkovic M, Vu THK, van Vught L, van Haren GR, Rodrigues MF, Klaver YLB, Verbist BM, Luyten GPM, Rasch CRN, Beenakker JM. Jaarsma-Coes MG, et al. Among authors: vu thk. Ophthalmol Retina. 2023 Feb;7(2):178-188. doi: 10.1016/j.oret.2022.06.019. Epub 2022 Jul 13. Ophthalmol Retina. 2023. PMID: 35840053 Free article.
Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma.
Klaassen L, Jaarsma-Coes MG, Verbist BM, Vu THK, Marinkovic M, Rasch CRN, Luyten GPM, Beenakker JM. Klaassen L, et al. Among authors: vu thk. Phys Imaging Radiat Oncol. 2022 Nov 7;24:102-110. doi: 10.1016/j.phro.2022.11.001. eCollection 2022 Oct. Phys Imaging Radiat Oncol. 2022. PMID: 36386446 Free PMC article.
Inter-Observer Variability in MR-Based Target Volume Delineation of Uveal Melanoma.
Jaarsma-Coes MG, Klaassen L, Verbist BM, Vu THK, Klaver YLB, Rodrigues MF, Nabarro C, Luyten GPM, Rasch CRN, van Herk M, Beenakker JM. Jaarsma-Coes MG, et al. Among authors: vu thk. Adv Radiat Oncol. 2022 Dec 24;8(3):101149. doi: 10.1016/j.adro.2022.101149. eCollection 2023 May-Jun. Adv Radiat Oncol. 2022. PMID: 36691449 Free PMC article.
MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.
Tang MCY, Ferreira TA, Marinkovic M, Jaarsma-Coes MG, Klaassen L, Vu THK, Creutzberg CL, Rodrigues MF, Horeweg N, Klaver YLB, Rasch CRN, Luyten GPM, Beenakker JM. Tang MCY, et al. Among authors: vu thk. Neuroradiology. 2023 Aug;65(8):1271-1285. doi: 10.1007/s00234-023-03166-1. Epub 2023 May 30. Neuroradiology. 2023. PMID: 37249621 Free PMC article.
17 results